Last $343.36 USD
Change Today +0.37 / 0.11%
Volume 971.8K
BIIB On Other Exchanges
As of 4:30 PM 08/27/14 All times are local (Market data is delayed by at least 15 minutes).
text size: T | T
Business Wire  06/09/2014 9:20 PM ET
SHAREHOLDER ALERT: Brower Piven Announces The Investigation Of Idenix Pharmaceuticals, Inc. In Connection With The Proposed Sale Of The Company To Merck & Co., Inc.

STEVENSON, Md.--(BUSINESS WIRE)--Jun. 9, 2014-- The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty to current shareholders of Idenix Pharmaceuticals, Inc. (“Idenix” or the “Company”) (NasdaqGS: IDIX) and other violations of state law by the board of directors of Merck & Co., Inc. (“Merck”), in a transaction valued at approximately $3.85 billion.

Under the terms of the transaction, shareholders of Idenix would receive $24.50 in cash for each share of Idenix they own. The firm's investigation seeks to determine, among other things, whether the Company's board of directors breached their fiduciary duties by failing to maximize shareholder value before agreeing to enter into this transaction, and whether Merck is underpaying for Idenix shares.

If you currently own common stock of Idenix and would like to learn more about the investigation being conducted by Brower Piven, without cost or obligation to you, please visit our website at You may also request more information by contacting Brower Piven either by email at or by telephone at (410) 415-6616.

Attorneys at Brower Piven have extensive experience in litigating securities and other class action cases and have been advocating for the rights of shareholders since the 1980s.

Source: Brower Piven, A Professional Corporation

Brower Piven, A Professional Corporation
Charles J. Piven, 410-415-6616
1925 Old Valley Road
Stevenson, Maryland 21153


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BIIB:US $343.36 USD +0.37

Industry News

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIOGEN IDEC INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at